Trials / Completed
CompletedNCT03196492
Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
Effect of Injectable Contraceptives on Inflammation, Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 234 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 13 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
The investigators are doing a study on the bacteria that normally live in the vagina and what effect, if any, Depo-Provera has on the bacteria. Women 13-24 years of age, who are HIV negative, being seen in a clinic for birth control or sexually transmitted disease (STD) check-up, or have a child and are planning to receive a Depo-Provera shot for contraception or have declined the use of hormonal contraception may join.
Detailed description
The investigators are doing a study on the bacteria that normally live in the vagina and what effect, if any, Depo-Provera has on the bacteria. Women 13-24 years of age, who are HIV negative, being seen in a clinic for birth control or STD check-up, or have a child and are planning to receive a Depo-Provera shot for contraception or have declined the use of hormonal contraception may join.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2017-06-14
- Primary completion
- 2021-06-14
- Completion
- 2021-06-14
- First posted
- 2017-06-22
- Last updated
- 2021-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03196492. Inclusion in this directory is not an endorsement.